Differential Effect of Heparin Coating and Complement Inhibition on Artificial Surface- Induced Eicosanoid Production  Knut Tore Lappegård, MD, Johan Riesenfeld,

Slides:



Advertisements
Similar presentations
Heparin-coated cardiopulmonary bypass equipment. II
Advertisements

Giant Transdiaphragmatic Intercostal Hernia
Effect of complement inhibition and heparin coating on artificial surface–induced leukocyte and platelet activation  Knut Tore Lappegård, MD, Michael.
Sally Bannan, Amanda Danby, Dahlia Cowan, Saeed Ashraf, Paul G Martin 
Attenuation of Changes in Leukocyte Surface Markers and Complement Activation With Heparin-Coated Cardiopulmonary Bypass  Oddvar Moen, MD, Kolbjørn Høgåsen,
Essential role of the C5a receptor in E coli–induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation.
Effect of Benidipine in Human Internal Mammary Artery and Clinical Implications  Hai-Tao Hou, BE, Jun Wang, BA, Zheng-Qing Wang, MD, Xiao-Cheng Liu, MD,
Differential Distribution of Lipid Microemboli After Cardiac Surgery
Spiral Tracheoplasty After Tangential Resection of Trachea
Clinical and Potential Use of Pharmacological Agents to Reduce Radial Artery Spasm in Coronary Artery Surgery  Saina Attaran, MD, Lindsay John, MD, Ahmed.
The Annals of Thoracic Surgery
Severe Pulmonary Valve Regurgitation 40 Years After Blunt Chest Trauma
Application of the Human Factors Analysis and Classification System Methodology to the Cardiovascular Surgery Operating Room  Andrew W. ElBardissi, BS,
ABO-Identical Blood Group Matching Has No Survival Benefit for AB Heart Transplant Recipients  Henrik Bergenfeldt, MD, Peter Höglund, MD, PhD, Bodil Andersson,
Long Esophageal Segment Laceration Caused by an Orogastric Tube During Laparoscopic Sleeve Gastrectomy  Sang Kuon Lee, MD, Jongho Lee, MD  The Annals.
Burdens Without Blessings: Peer Reviewers Get No Respect
The effects of carmeda bioactive surface on human blood components during simulated extracorporeal circulation  Robert L. Korn, MD, PhD, Carol A. Fisher,
Clinical Outcome After Poststernotomy Mediastinitis: Vacuum-Assisted Closure Versus Conventional Treatment  Johan Sjögren, MD, Ronny Gustafsson, MD, PhD,
Anomalous Great Cardiac Vein Draining Into the Superior Vena Cava
Denton A. Cooley, August 22, 1920, to November 18, 2016
Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H
Potassium Channel-Related Relaxation by Levosimendan in the Human Internal Mammary Artery  Oguzhan Yildiz, MD, PhD, Melik Seyrek, MD, Vedat Yildirim,
Sarah M. Brant, MD, Michael L. Cobert, PhD, LaShondra M
Surgical Resection of a Giant Coronary Aneurysm
Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD 
Pleural Metastasis of Osteosarcoma
Twisted Wire Stent Technique for Delayed Sternal Closure After Congenital Heart Operations  Ersin Erek, MD, Mehmet Kaya, MD, Cansaran Tanidir, MD, Ozgen.
Origins of the Cardiothoracic Surgery Network (CTSNet)
Joseph D. Whitlark, MD, RVT, Joseph A. Kirollos, Spencer M
Who Do You Say You Are? The Annals of Thoracic Surgery
Use of Recombinant Activated Factor VII Concentrate to Control Postoperative Hemorrhage in Complex Cardiovascular Surgery  Lyndsey J. Bowman, Walter E.
Use of Amiodarone After Major Lung Resection
Surgical Dilemmas: Diagnosis and Treatment of Atrial Plasmacytoma
Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence  Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,
Anomalous Origin of Left Pulmonary Artery From Left Subclavian Artery
Lei Yu, MD, Tianxiang Gu, MD, PhD, Zongyi Xiu, MD, PhD 
Percutaneous Transcatheter Closure of the Aortic Valve
Neurofibromatosis of the Esophagus
Embolized Methyl Methacrylate to the Right Atrium After Kyphoplasty
Cassandra Joffs, MD, Himali R. Gunasinghe, BS, Marlina M
Editorial Board, January 2010
Sarah C. Huen, MD, Chirag R. Parikh, MD, PhD 
Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor
PillCam in Gastric Conduit After Ivor Lewis Esophagectomy
An Unusual Cause of Hemoptysis in a Young Woman
Postoperative Pleural Effusion in Bronchioloalveolar Cancer
Vacuum-Assisted Closure for the Treatment of Complex Chest Wounds
Deterioration of a Tricuspid Bioprosthesis Due to Adhesion of the Native Valve  Herbert Gutermann, MD, Willem Flameng, MD, PhD, Paul Herijgers, MD, PhD 
The Unifocal Bilateral Bidirectional Cavopulmonary Anastomosis
Christine S. Rinder, MD, Michael J. Smith, PhD, Henry M
Role of Endothelin-1 Receptor Antagonists in Vasoconstriction Mediated by Endothelin and Other Vasoconstrictors in Human Internal Mammary Artery  Guo-Wei.
No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits  Christian Olsson, MD, Agneta Siegbahn, MD, PhD,
Two Consecutive Open Heart Operations in a Small Child With Heparin-Induced Thrombocytopenia Type II Using Anticoagulation With Heparin and Tirofiban 
Effect of modified ultrafiltration on plasma thromboxane B2, leukotriene B4, and endothelin-1 in infants undergoing cardiopulmonary bypass  Jeffrey M.
Sequential Design for Clinical Trials Evaluating a Prosthetic Heart Valve  Cody Hamilton, PhD, Michael Lu, PhD, Steven Lewis, PhD, William Anderson, PhD 
Specialty Training and Mortality After Esophageal Cancer Resection
The Complement System Is Activated in a Biphasic Pattern After Coronary Artery Bypass Grafting  Cornelia Hoedemaekers, MD, PhD, Marcel van Deuren, MD,
Scott B. Johnson, MD, Anna M. Allred, BS, Adam M. Cline, MD, Luis F
Invited Commentary The Annals of Thoracic Surgery
Robert Lee Replogle, September 30, 1931–May 9, 2016
A Target for Perioperative Blood Pressure During Cardiac Operations
The American Board of Thoracic Surgery: Update
Grethe Bergseth, BS, John D
“Transitions” for Cardiothoracic Surgeons Now Listed on the Web:
Late Consequences of a Much Earlier Decision
An Assay to Monitor Bivalirudin Levels on Cardiopulmonary Bypass
The Impact of New Technology on Cardiothoracic Surgical Practice
Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD 
J. Alberto Lopez, MD  The Annals of Thoracic Surgery 
Factors in the Selection and Management of Chest Tubes After Pulmonary Lobectomy: Results of a National Survey of Thoracic Surgeons  Samuel S. Kim, MD,
Presentation transcript:

Differential Effect of Heparin Coating and Complement Inhibition on Artificial Surface- Induced Eicosanoid Production  Knut Tore Lappegård, MD, Johan Riesenfeld, PhD, Ole-Lars Brekke, MD, PhD, Grethe Bergseth, BS, John D. Lambris, PhD, Tom Eirik Mollnes, MD, PhD  The Annals of Thoracic Surgery  Volume 79, Issue 3, Pages 917-923 (March 2005) DOI: 10.1016/j.athoracsur.2004.08.015 Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Polyvinyl chloride-induced (PVC) synthesis of leukotriene B4 (LTB4) (pg/mL) in human whole blood. Human whole blood, with or without complement inhibitors or indomethacin, was circulated for 4 hours in segments of tubing rotated as closed loops, whereupon the LTB4 concentration in plasma was measured by enzyme-linked immunosorbent assay. (T0 = baseline values; PVC = PVC loops. Heparin = heparin-coated loops; Compstatin 5 or 25 μmol/L; C5aRA = C5a receptor antagonist 1 or 5 μmol/L; indomethacin 2 or 10 μmol/L. Inhibitors were added to blood incubated in uncoated PVC only; # = p < 0.001 versus baseline; * = p < 0.05; ** = p < 0.02; *** = p < 0.01; **** = p < 0.001; all versus PVC; data are presented as mean ± standard error of the mean). The Annals of Thoracic Surgery 2005 79, 917-923DOI: (10.1016/j.athoracsur.2004.08.015) Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Polyvinyl chloride-induced (PVC) synthesis of prostaglandin E2 (PGE2) (pg/mL) in human whole blood. Human whole blood, with or without complement inhibitors or indomethacin, was circulated for 4 hours in segments of tubing rotated as closed loops, whereupon the PGE2 concentration in plasma was measured by enzyme-linked immunosorbent assay. (T0 = baseline values; PVC = PVC loops; Heparin = heparin-coated loops; Compstatin 5 or 25 μmol/L; C5aRA = C5a receptor antagonist 1 or 5 µmol/L; indomethacin 2 or 10 μmol/L. Inhibitors were added to blood incubated in uncoated PVC only; # = p < 0.001 versus baseline; * = p < 0.05; *** = p < 0.01; **** = p < 0.001; all versus PVC; data are presented as mean ± standard error of the mean). The Annals of Thoracic Surgery 2005 79, 917-923DOI: (10.1016/j.athoracsur.2004.08.015) Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Polyvinyl chloride-induced (PVC) synthesis of thromboxane B2 (TXB2) (pg/mL) in human whole blood. Human whole blood, with or without complement inhibitors or indomethacin, was circulated for 4 hours in segments of tubing rotated as closed loops, whereupon the TXB2 concentration in plasma was measured by enzyme-linked immunosorbent assay. (T0 = baseline values; PVC = PVC loops; Heparin = heparin-coated loops; Compstatin 5 or 25 μmol/L; C5aRA = C5a receptor antagonist 1 or 5 μmol/L; indomethacin 2 or 10 μmol/L. Inhibitors were added to blood incubated in uncoated PVC only; data are presented as mean ± standard error of the mean; # = p < 0.001 versus baseline; * = p < 0.05; **** = p < 0.001; both versus PVC.) The Annals of Thoracic Surgery 2005 79, 917-923DOI: (10.1016/j.athoracsur.2004.08.015) Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Polyvinyl chloride-induced (PVC) complement activation in human whole blood. Human whole blood, with or without complement inhibitors, was circulated for 4 hours in segments of tubing rotated as closed loops, whereupon the concentration of the terminal complement complex (TCC) in plasma was measured by enzyme-linked immunosorbent assay. (T0 = baseline values; PVC = PVC loops; Heparin = heparin-coated loops; Compstatin 5 or 25 μmol/L; C5aRA = C5a receptor antagonist 1 or 5 μmol/L; indomethacin 2 or 10 μmol/L. Inhibitors were added to blood incubated in uncoated PVC only; data are presented as mean ± standard error of the mean; AU = arbitrary units; # = p < 0.001 versus baseline; *** = p < 0.01 versus PVC.) The Annals of Thoracic Surgery 2005 79, 917-923DOI: (10.1016/j.athoracsur.2004.08.015) Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions